SNCA and Parkinson disease: For PD, alpha-synuclein-targeted gene therapy was demonstrated using Fe3O4 NPs functionalized with a smart hydrogel (N-isopropylacrylamide derivative, NIPAm-AA) responsive to temperature and pH.